Commvault Prescribes Cyber Resilience for Continuous Patient Care at HIMSS25

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Visit Booth #C1027 to find the right course of action for protecting and securing healthcare data

TINTON FALLS, N.J., Feb. 19, 2025 /PRNewswire/ — Commvault, a leading provider of cyber resilience and data protection solutions for hybrid environments, will be handing out the prescription for uninterrupted patient care at HIMSS25 in Las Vegas from March 3-6. By visiting Booth #C1027, hospitals and healthcare providers can learn how to guard against one of the most lethal threats to patient data – ransomware – while uncovering how to sustain continuous business operations. Attendees are encouraged to explore Commvault’s speaking sessions and immerse themselves in a cyber meltdown simulation designed to underscore the critical need for comprehensive cyber resilience.

Commvault’s recommended approach includes:

  • Building the Business Case for Enhanced Cyber Readiness Investments
    March 4 | 2:40 PM | Cybersecurity Command Center – Theater A | Caesars Forum Alliance Ballroom 
    • Having a solid cyber resilience strategy in place can make all the difference for fast and effective data recovery. Join Microsoft’s David Houlding, Director of Global Healthcare Security & Compliance Strategy and Commvault’s Mike Carroll, Area Vice President, to discuss best practices for protecting data across cloud and hybrid environments. Learn why proactive investments in cyber readiness are crucial for any healthcare organization.
    • Rx: Add to your schedule
  • Healthcare Minutes to Meltdown: Experience a Cyber Meltdown
    March 4 | 3:00 PM | Smith & Wollensky Private Room Venetian Canal Shops, Level 2
    • When every second counts, even small gaps in preparedness can devastate patient care. In this immersive simulation, discover how cyberattacks can cripple critical systems, disrupt operations, and lead to catastrophic outcomes – and learn what your organization can do to stay ahead of bad actors.
    • Rx: Register now
  • Fortify Healthcare: Cyber Resilience Against Growing Threats
    March 5 | 10:00 AM | Cybersecurity Command Center – Theater A | Caesars Forum Alliance Ballroom 
    • Being cyber resilient means having effective safeguards in place – and knowing exactly how to activate them when needed. Join Commvault’s Vice President, Product Experience, Michael Stempf as he details the latest defense and recovery tactics you can integrate into any healthcare environment.
    • Rx: Add to your schedule

When it comes to patient care, taking risks is not an option. With Commvault Cloud, organizations can protect sensitive records, accelerate recovery, and minimize downtime.

To learn more about how Commvault enables cyber resilience for healthcare organizations, click here or schedule a check-up with Commvault at HIMSS, Booth #C1027. Additional dosage details can be found here.

About Commvault
Commvault (NASDAQ: CVLT) is the gold standard in cyber resilience, helping more than 100,000 organizations keep data safe and businesses resilient and moving forward. Today, Commvault offers the only cyber resilience platform that combines the best data security and rapid recovery at enterprise scale across any workload, anywhere—at the lowest TCO.

View original content to download multimedia:https://www.prnewswire.com/news-releases/commvault-prescribes-cyber-resilience-for-continuous-patient-care-at-himss25-302378984.html

SOURCE COMMVAULT

Staff

Recent Posts

Norton Orthopedic Institute surgeon performs new robotic-assisted shoulder replacement

Justin M. Givens, M.D., is among first five surgeons in U.S. to perform the surgery…

2 hours ago

Transforming Wellness: Abundant Health Introduces RENEW Protocols for Lasting Relief

Davenport, Iowa, March 28, 2025 (GLOBE NEWSWIRE) -- Abundant Health Physical Medicine, a leading integrative…

2 hours ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi”…

2 hours ago

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous…

2 hours ago

Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data

Silexion’s new expanded dual-route strategy will integrate intratumoral and systemic administration to target both primary…

2 hours ago